1. Home
  2. BBSI vs ODTX Comparison

BBSI vs ODTX Comparison

Compare BBSI & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barrett Business Services Inc.

BBSI

Barrett Business Services Inc.

HOLD

Current Price

$31.33

Market Cap

781.3M

ML Signal

HOLD

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$20.86

Market Cap

875.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BBSI
ODTX
Founded
1965
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
781.3M
875.1M
IPO Year
1994
2025

Fundamental Metrics

Financial Performance
Metric
BBSI
ODTX
Price
$31.33
$20.86
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$42.67
N/A
AVG Volume (30 Days)
260.8K
129.6K
Earning Date
05-06-2026
N/A
Dividend Yield
1.01%
N/A
EPS Growth
5.05
N/A
EPS
N/A
N/A
Revenue
$920,432,000.00
N/A
Revenue This Year
$6.59
N/A
Revenue Next Year
$6.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.50
N/A
52 Week Low
$25.33
$15.10
52 Week High
$49.65
$23.08

Technical Indicators

Market Signals
Indicator
BBSI
ODTX
Relative Strength Index (RSI) 31.42 56.42
Support Level $26.86 $15.10
Resistance Level $31.99 N/A
Average True Range (ATR) 1.47 1.69
MACD -0.89 0.09
Stochastic Oscillator 7.95 57.36

Price Performance

Historical Comparison
BBSI
ODTX

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of business management solutions for small and mid-sized companies through a platform that combines management consulting expertise with human resource tools to help business owners manage and operate their businesses more effectively. The company has two categories of services: Professional Employer Services (PEO) and Staffing. The majority of revenue is derived from the Professional Employer Services segment, which provides clients with human resource advisory services, HRIS access, retirement plans, a learning management system, and a web-based technology platform, myBBSI.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: